Abstract
Tumor development leading to cancer is a complex process involving several steps. Among them, angiogenesis, ie growth of new tumor induced blood vessels is one of the most important therapeutic targets in the search for anticancer agents. One point which remain to be addressed is the detection of tumor angiogenic areas, ie tumor angiogenesis imaging. After presenting the key points of tumor development which lead to neoangiogenesis, and providing an overview of the main therapeutic approaches in this field, this review focusses on the recent progress in angiogenesis imaging, namely the one dealing with matrix metalloproteases. These enzymes are indeed present to major phenomena of the tumor progression. The different imaging approaches are described, namely the ones using optical, radiochemical or magnetic resonance ones.
Keywords: Cancer imaging, MMPs, angiogenesis, molecular imaging, PET, SPECT, MRI, optical imaging
Anti-Cancer Agents in Medicinal Chemistry
Title: New Trends in Molecular Imaging of Tumor Angiogenesis
Volume: 8 Issue: 5
Author(s): Thomas Berthelot, Marie-Claire Lasne and Gerard Deleris
Affiliation:
Keywords: Cancer imaging, MMPs, angiogenesis, molecular imaging, PET, SPECT, MRI, optical imaging
Abstract: Tumor development leading to cancer is a complex process involving several steps. Among them, angiogenesis, ie growth of new tumor induced blood vessels is one of the most important therapeutic targets in the search for anticancer agents. One point which remain to be addressed is the detection of tumor angiogenic areas, ie tumor angiogenesis imaging. After presenting the key points of tumor development which lead to neoangiogenesis, and providing an overview of the main therapeutic approaches in this field, this review focusses on the recent progress in angiogenesis imaging, namely the one dealing with matrix metalloproteases. These enzymes are indeed present to major phenomena of the tumor progression. The different imaging approaches are described, namely the ones using optical, radiochemical or magnetic resonance ones.
Export Options
About this article
Cite this article as:
Berthelot Thomas, Lasne Marie-Claire and Deleris Gerard, New Trends in Molecular Imaging of Tumor Angiogenesis, Anti-Cancer Agents in Medicinal Chemistry 2008; 8 (5) . https://dx.doi.org/10.2174/187152008784533026
DOI https://dx.doi.org/10.2174/187152008784533026 |
Print ISSN 1871-5206 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5992 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Long-Term Psychosexual Development in Genetic Males Affected by Disorders of Sex Development (46,XY DSD) Reared Male or Female
Current Pediatric Reviews Hsp90 Inhibitor Geldanamycin and Its Derivatives as Novel Cancer Chemotherapeutic Agents
Current Pharmaceutical Design P-gp Inhibition-Based Strategies for Modulating Pharmacokinetics of Anticancer Drugs: An Update
Current Drug Metabolism Using Cytochalasins to Improve Current Chemotherapeutic Approaches
Anti-Cancer Agents in Medicinal Chemistry Disintegrin Tablysin-15 Suppresses Cancer Hallmarks in Melanoma Cells by Blocking FAK/Akt/ERK and NF-κB Signaling
Current Cancer Drug Targets Role of mTOR in Hematological Malignancies
Current Cancer Therapy Reviews Review on EGFR Inhibitors: Critical Updates
Mini-Reviews in Medicinal Chemistry Subject Index To Volume 7
Current Drug Metabolism Do Not Say Ever Never More: The Ins and Outs of Antiangiogenic Therapies
Current Pharmaceutical Design Impact of Splicing Factor Mutations on Pre-mRNA Splicing in the Myelodysplastic Syndromes
Current Pharmaceutical Design Biosafety of Adenoviral Vectors
Current Gene Therapy The Forward Path for Biopharmaceuticals and Biosimilars: Emerging Options in the Selection of Host Cell Systems
Current Biotechnology Genetic and Epigenetic Studies for Determining Molecular Targets of Natural Product Anticancer Agents
Current Cancer Drug Targets Schiff Bases and Complexes: A Review on Anti-Cancer Activity
Anti-Cancer Agents in Medicinal Chemistry PPARγ Agonists in Combination Cancer Therapies
Current Cancer Drug Targets Pathophysiology and Treatment of Diabetic Peripheral Neuropathy: The Case for Diabetic Neurovascular Function as an Essential Component
Current Diabetes Reviews Skp2 Inhibitors: Novel Anticancer Strategies
Current Medicinal Chemistry Meet Our Regional Editor
Current Gene Therapy Hemophagocytic Lymphohistiocytosis (HLH): An Update
Current Immunology Reviews (Discontinued) Affective Disorder and Hyperandrogenism
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)